MindMed Reports Second Quarter 2022 Financial Results and Business Highlights

Can Psilocybin Treat Obesity? New Evidence, Future Directions

Psilera’s New Compounds Show Potential for Significant Treatment Improvement in Depression...

Mindset Pharma CEO, James Lanthier, Issues Letter to Shareholders

PsyBio Therapeutics Announces Expansion of Patent Portfolio with Additional Global Patent...

Optimi Health To Launch Therapeutic Psilocybin Product In Partnership With Patient...

PT345 – Steve Thayer, Ph.D. – Vital Psychedelic Conversations

Buried Treasure: How Does Psilocybin Reduce Compulsivity?

Field Trip Health Ltd. Schedules Fiscal First Quarter 2023 Conference Call...

Psychedelic Bulletin #113 – Analysis of Company Spending Trends; Morgan Stanley...

Load more